@misc{indiciae0726b0394155,
  title = {Next-generation monoclonals less profitable than trailblazers?},
  author = {Peter Mitchell},
  year = {2005},
  doi = {10.1038/nbt0805-906},
  url = {https://pubmed.ncbi.nlm.nih.gov/16082347/},
  note = {Source identifier: 16082347}
}